Identifying reliable biomarkers for MDSCs is crucial for the development of therapeutic strategies and for monitoring treatment responses. Common biomarkers include surface markers such as CD11b, CD33, and HLA-DR. Additionally, functional markers like arginase activity, ROS production, and certain cytokine profiles can also serve as indicators of MDSC presence and activity.
